OpenBilldrug price receipt

NADAC week of 2026-10-14

PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE)

FDA nonproprietary name: nirmatrelvir and ritonavir

For 1 unit (EA)

Pharmacies pay

$73.79 filed

1 × $73.78524 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$89.86 estimated

$73.79 + $11.07 (15%) + $5.00 fee per fill = $89.86

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) is how the CMS NADAC file names this product. The FDA NDC Directory lists it as nirmatrelvir and ritonavir, under the trade name “Paxlovid”.

FDA gives its dosage form as kit.

The labeler, the company named on the label, is Pfizer Laboratories Div Pfizer Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00069-5434-20.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $73.79 for 1 unit (EA) (1 × $73.78524 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name nirmatrelvir and ritonavir with PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE).

ProductPharmacies pay per unitMedicare per unit
PAXLOVID 150-100 MG DOSE PACK (MODERATE RENAL DOSE) this page
brand · kit
$73.78524 per EA filed
eff. 2026-09-23
We don’t know yet
PAXLOVID 300-100 MG DOSE PACK
brand · kit
$49.23712 per EA filed
eff. 2026-09-23
We don’t know yet
PAXLOVID 300/150-100 MG DOSE PACK (SEVERE RENAL DOSE)
brand · kit
$133.96709 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.